Archives
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
Findings seen among 33,995 individuals aged 40 years and older with untreated hypertension
Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia
Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use
CDC Provides Update on Measles Outbreak in the United States
Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas
Risky Health Behaviors Tied to Poorer Mental Well-Being, General Health in Midlife
Association even stronger for accumulation of healthy behaviors over time
Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction
In a recent study, one-year MACE incidences were 1.79, 2.58, and 4.03 per 100 patient-years for early, late, and no ezetimibe added to statins
Efanesoctocog Alfa Not Cost-Effective for Prophylaxis in Hemophilia A
Efanesoctocog alfa needs to be priced at <53 and <59 percent of current price for conventional and distributional cost-effectiveness
Recent Years Saw Increase in Youth With Anxiety, Depression
Increase seen in proportion with anxiety and depression, while proportion experiencing behavioral or conduct problems remained stable
Disparities Identified in Linkage to Care for Children With Hepatitis C
Hispanic/Latinx and White children have more than twofold and threefold increased odds of linkage to care, respectively, than Black children
32 Percent of Dementia Attributed to Audiometric Hearing Loss
No association seen for self-reported hearing loss with increased risk for dementia in community-dwelling seniors during up to eight years of follow-up
